Physician profile
Cheryl Harris
NPI 1841225075
$828.29
in general payments reported to CMS, 2019-2025
19 companies · $212 in 2025
The $212 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $35.19 · 2022: $85.46 · 2023: $217 · 2024: $118 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $143.84 | 2023-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $129.62 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $72.59 | 2019-2025 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $70.34 | 2022-2024 | Vaxelis, Gardasil 9, Vaqta |
| Sanofi-Aventis U.S. LLC | $47.07 | 2025 | |
| Pfizer INC. | $46.87 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $42.65 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $41.29 | 2019-2020 | |
| Sobi, INC | $33.04 | 2019-2023 | |
| Sanofi Pasteur INC. | $32.45 | 2019-2022 | |
| Dermira, INC. | $28.39 | 2019 | |
| Ironwood Pharmaceuticals, INC | $20.54 | 2023 | Linzess |
| Ultragenyx Pharmaceutical INC. | $19.82 | 2023 | |
| Supernus Pharmaceuticals, INC. | $19.05 | 2025 | Qelbree |
| Neos Therapeutics, LP | $17.96 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $17.62 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.18 | 2025 | Zoryve |
| Cranial Technologies, INC | $15.17 | 2023 | Doc Band |
| Shire North American Group INC | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.